News for Almaden Minerals Ltd. (0UH8.L)

VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (”œAlmaden” or ”œthe Company”; TSX: AMM; AAUAF) is pleased to ann

**media[555331]**

VANCOUVER, British Columbia, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (”œAlmaden” or ”œthe Company”; TSX: AMM; AAUAF) provides an update

VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) is pleased to...

VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or the “Company”; TSX: AMM; OTCQB: AAUAF) is pleased to announce th…

VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden

VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (together with its Mexican Subsidiary, Minera Gorrión S.A. de C.V.,...

VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Almadex Minerals Ltd. (

VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) -- Almadex Minerals Ltd. (

ALMADEN MINERALS LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS March 31, 2024 INTRODUCTION This...

NOTICE OF NO AUDITOR REVIEW OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS The accompanying unaudited condensed consolidated interim financial statements...

VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) —

Gainers YS Biopharma Co., Ltd. (NASDAQ: YS) shares rose 90.3% to $2.36 in pre-market trading after dropping over 7% on Monday. YS Biopharma's PIKA Rabies Vaccine recently received Phase 3 clinical trial approval from Philippines FDA.

Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday.